Medical News

RSS

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

Researchers tested 5-amino levulinic acid in vitro in human-derived cells and found it prevents severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Because it is safe and ubiquitous in plants and animals, it could be a potential drug against SARS-CoV-2.

1 Nov 2020

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.

30 Oct 2020

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging.

30 Oct 2020

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein.

30 Oct 2020

Researchers seek to understand HIV-related attitudes of nursing faculty in six countries

Since the earliest study about nursing faculty and students attitudes and beliefs about caring for people living with HIV/AIDS (PLHIV) in the early 1990's, there have only been 17 additional studies. Knowledge in this area of study is still lacking to fill some gaps in understanding attitudes towards people living with the disease.

30 Oct 2020

Potential treatment might make tumors more responsive to immunotherapy

Cancer immunotherapies, which empower patients' immune systems to eliminate tumors, are revolutionizing cancer treatment. Many patients respond well to these treatments, sometimes experiencing long-lasting remissions.

30 Oct 2020

Glucose-lowering drugs have neutral effect on mortality, adverse outcomes in COVID-19 patients with type 2 diabetes

In a preprint paper, "Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19," researchers conclude a neutral effect on mortality and other adverse outcomes.

30 Oct 2020

Mobile smartphone technology may be key to improving out-of-hospital cardiac arrest survival

Mobile smartphone technology can accelerate first responder dispatch and may be instrumental to improving out of hospital cardiac arrest (OCHA) survival.

30 Oct 2020

Researchers report a novel approach to generate T-cells faster

Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment.

30 Oct 2020

Princeton professor selected to receive new award recognizing faculty innovation

Robert Prud'homme, professor of chemical and biological engineering at Princeton University, has been selected to receive the inaugural Dean for Research Award for Distinguished Innovation for the invention of flash nanoprecipitation, a method for creating nanoparticles that promises to improve the delivery of drugs throughout the body.

30 Oct 2020

COVID-19 spreads faster and more widely in U.S. households, finds study

COVID-19 spreads faster and more widely throughout U.S. households than previously reported, according to new preliminary research from a multicenter study led by Vanderbilt University Medical Center researchers and published in MMWR, a weekly report from the Centers for Disease Control and Prevention.

30 Oct 2020

Collective impact partnership models help address critical gaps in health care workforce

Currently, approximately 1.6 million Virginians live in primary care shortage areas and 2.2 million in mental health care shortage areas (Kaiser Family Foundation, 2019), yet only three percent of Virginia's high school career and technical education courses are in the health sciences.

30 Oct 2020

Terror groups exploit the mayhem during COVID-19 for spinning a plethora of sinister schemes

The uncertainty and confusion caused by the COVID-19 pandemic is being "widely exploited by terror groups for spinning a plethora of sinister schemes", which could lead to a new tide of violence against people and governments.

30 Oct 2020

Washing hands and Halloween candy can reduce COVID-19 exposure risk

New research shows that COVID-19 exposure risk from contaminated candy could be successfully mitigated both by washing hands and washing candy using a simple at-home method. A team of researchers published this work today in mSystems, an open-access journal of the American Society for Microbiology.

30 Oct 2020

Researchers identify new drug candidate with potential to treat COVID-19

Researchers from the University of Kent, the Goethe-University in Frankfurt am Main (Germany), and the Hannover Medical School (Germany) have identified a drug with the potential to provide a treatment for COVID-19.

30 Oct 2020

Study identifies new cause of inflammation in people living with HIV

While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.

30 Oct 2020

Study analyzes the viral load on Halloween candy handled by COVID-19 patients

Like a specter, the question looms: How risky is trick-or-treating with SARS-Cov-2, the virus that causes COVID-19, in the air -- and possibly on the candy?

30 Oct 2020

IHR Emergency Committee on COVID-19 urges focus on evidence-based response efforts

The Emergency Committee on COVID-19 met on 29 October to review the situation and progress made on the temporary recommendations. They advised that the pandemic still constituted a public health emergency of international concern, and urged a focus on response efforts based on lessons learned and strong science.

30 Oct 2020

Collaborative effort will enable efficient oversight to prevent illegal, harmful products from entering the U.S.

Recently, leadership from the U.S. Food and Drug Administration, the U.S. Customs and Border Protection, and the U.S. Immigration and Customs Enforcement, Homeland Security Investigations signed a Memorandum of Understanding to stop harmful products that pose a threat to public health and attempt to enter the U.S. through International Mail Facilities.

30 Oct 2020

E-health app supported care improves COPD outcomes compared to usual treatment

COPD is a common respiratory condition and one of the top causes of hospital admissions each year, particularly during winter months. In the UK it accounts for over 140,000 hospital admissions and one million bed days at a major cost to the NHS.

30 Oct 2020

Medical News

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Researchers seek to understand HIV-related attitudes of nursing faculty in six countries

Potential treatment might make tumors more responsive to immunotherapy

Glucose-lowering drugs have neutral effect on mortality, adverse outcomes in COVID-19 patients with type 2 diabetes

Mobile smartphone technology may be key to improving out-of-hospital cardiac arrest survival

Researchers report a novel approach to generate T-cells faster

Princeton professor selected to receive new award recognizing faculty innovation

COVID-19 spreads faster and more widely in U.S. households, finds study

Collective impact partnership models help address critical gaps in health care workforce

Terror groups exploit the mayhem during COVID-19 for spinning a plethora of sinister schemes

Washing hands and Halloween candy can reduce COVID-19 exposure risk

Researchers identify new drug candidate with potential to treat COVID-19

Study identifies new cause of inflammation in people living with HIV

Study analyzes the viral load on Halloween candy handled by COVID-19 patients

IHR Emergency Committee on COVID-19 urges focus on evidence-based response efforts

Collaborative effort will enable efficient oversight to prevent illegal, harmful products from entering the U.S.

E-health app supported care improves COPD outcomes compared to usual treatment

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News